COMMUNIQUÉS West-GlobeNewswire
-
Route 92 Medical Celebrates the 200th Patent for its Neurovascular Intervention Portfolio
20/07/2026 -
Northwestern Medicine Announces the Robert Havey, MD, Institute for Primary Care
20/07/2026 -
Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
20/07/2026 -
Virbac: croissance solide de +7,4 % à PCC au premier semestre 2026, portée par la hausse à deux chiffres de nos plateformes Supercharge⁴
20/07/2026 -
A Father's Gift, A World First: Six-Year-Old Becomes First Patient to Receive a Liver Transplant Through a Single Robotic Incision
20/07/2026 -
New resources on the way for BC farms under pressure from pests and disease
20/07/2026 -
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
20/07/2026 -
CurePSP Awards Record Pathway and Pipeline Grants to Advance PSP and CBD Research
20/07/2026 -
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
20/07/2026 -
TOMI Environmental and Carbonium Core Positioned To Play Key Role in The Onshoring of Essential Strategic Materials for Defense and Global Disinfection
20/07/2026 -
Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities
20/07/2026 -
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
20/07/2026 -
Applied Biologics Announces Submission of XWRAP® Translational Research Abstract for Consideration at SAWC Fall 2026
20/07/2026 -
Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry
20/07/2026 -
Novo Nordisk A/S - share repurchase programme
20/07/2026 -
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
20/07/2026 -
ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
20/07/2026 -
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
20/07/2026 -
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
20/07/2026
Pages